Siemens Healthcare has received FDA clearance for their MAMMOMAT Inspiration Prime Edition lower dose mammography system.
Siemens Healthcare has received FDA clearance for their MAMMOMAT Inspiration Prime Edition mammography system, which lowers radiation dose by up to 30 percent, the company said.
This latest MAMMOMAT system reduces dose by replacing the standard scatter radiation grid with a new algorithm for progressive image reconstruction, according to Siemens. The algorithm can identify scatter-causing structures and calculating a corrected image. This may enable the complete use of primary radiation to achieve lower dose, the company said.
The design of the MAMMOMAT Inspiration Prime Edition obviates the need for a grid, the company said, and lower doses compared to the predecessor model are needed for high-quality images. This edition is based the MAMMOMAT Inspiration platform which has been used since 2007.
Mammography and Breast MRI: Is it Time to Evaluate Strategies as Opposed to Modalities?
July 5th 2024The combination of mammography with breast MRI within 90 days had a 96.2 percent sensitivity in comparison to 48.1 percent for mammography and 79.7 percent for breast MRI performed within 91 to 270 days after index mammography, according to newly published research.
ACR Collaborative Model Leads to 35 Percent Improvement with Mammography Positioning Criteria
July 1st 2024Noting significant variation with facilities for achieving passing criteria for mammography positioning, researchers found that structured interventions, ranging from weekly auditing of images taken by technologists to mechanisms for feedback from radiologists to technologists, led to significant improvements in a multicenter study.